These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10634522)

  • 1. Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation.
    Kurtek RW; Lai KK; Tauxe WN; Eidelman BH; Fung JJ
    Clin Nucl Med; 2000 Jan; 25(1):7-10. PubMed ID: 10634522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-HMPAO cerebral perfusion scintigraphy: considerations for timely brain death declaration.
    Larar GN; Nagel JS
    J Nucl Med; 1992 Dec; 33(12):2209-11. PubMed ID: 1460517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime.
    Costa DC; Motteux IM; McCready AC
    Eur J Nucl Med; 1991; 18(7):503-6. PubMed ID: 1915475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of brain death: superiority of perfusion studies with 99Tcm-HMPAO over conventional radionuclide cerebral angiography.
    de la Riva A; González FM; Llamas-Elvira JM; Latre JM; Jiménez-Heffernan A; Vidal E; Martínez M; Torres M; Guerrero R; Alvarez F
    Br J Radiol; 1992 Apr; 65(772):289-94. PubMed ID: 1581783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [99mTc HMPAO (technetium 99m-hexamethylpropyleneamine oxime) angioscintigraphy in the diagnosis of brain death].
    Abate A; Chini G; Amantini A; Ragazzoni A; Pieroni C
    Minerva Anestesiol; 1995; 61(7-8):329-34. PubMed ID: 8948745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HM-PAO cerebral blood flow scintigraphy in the manifestation stage of brain death].
    Berlit P; Wetzel E
    Nervenarzt; 1992 Feb; 63(2):101-4. PubMed ID: 1565165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of brain death with Tc-99m HMPAO.
    Wilson K; Gordon L; Selby JB
    Clin Nucl Med; 1993 May; 18(5):428-34. PubMed ID: 8508581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m HMPAO cerebral scintigraphy. A reliable, noninvasive method for determination of brain death.
    Wieler H; Marohl K; Kaiser KP; Klawki P; Frössler H
    Clin Nucl Med; 1993 Feb; 18(2):104-9. PubMed ID: 8432051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hollow skull: a sign of brain death in Tc-99m HM-PAO brain scintigraphy.
    Abdel-Dayem HM; Bahar RH; Sigurdsson GH; Sadek S; Olivecrona H; Ali AM
    Clin Nucl Med; 1989 Dec; 14(12):912-6. PubMed ID: 2605849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of Tc-99m DTPA and Tc-99m HMPAO for evaluating brain death.
    Spieth ME; Ansari AN; Kawada TK; Kimura RL; Siegel ME
    Clin Nucl Med; 1994 Oct; 19(10):867-72. PubMed ID: 7805319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral perfusion imaging with technetium-99m HM-PAO in brain death and severe central nervous system injury.
    Laurin NR; Driedger AA; Hurwitz GA; Mattar AG; Powe JE; Chamberlain MJ; Zabel PL; Pavlosky WF
    J Nucl Med; 1989 Oct; 30(10):1627-35. PubMed ID: 2795203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-HMPAO perfusion SPECT/CT in the diagnosis of brain death.
    Derlin T; Weiberg D
    Nucl Med Rev Cent East Eur; 2016; 19(B):22-23. PubMed ID: 27900758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-hexamethylpropylene amine oxime lung scintigraphy findings in patients with Behçet's disease.
    Gumuser G; Pirildar T; Tarhan S; Batok D; Ruksen E; Sakar A; Sayit E
    Nucl Med Commun; 2011 May; 32(5):363-8. PubMed ID: 21394049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of technetium-99m HM-PAO for determination of brain death.
    Reid RH; Gulenchyn KY; Ballinger JR
    J Nucl Med; 1989 Oct; 30(10):1621-6. PubMed ID: 2795202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancillary radionuclide perfusion studies in the determination of death by neurologic criteria: methods, interpretation, and lexicon-a user guide for the clinician.
    Zuckier LS; McKinnon NK
    Can J Anaesth; 2023 Apr; 70(4):771-780. PubMed ID: 37131034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of brain death using 99m Tc HM-PAO.
    Adelstein W
    J Neurosci Nurs; 1994 Apr; 26(2):118-20. PubMed ID: 8077773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of brain death--own experience.
    Kraft O; Samlík J; Chmelová J
    Nucl Med Rev Cent East Eur; 2006; 9(2):132-7. PubMed ID: 17304476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy in the differential diagnosis of cerebral abscesses.
    Spinelli F; Sara R; Milella M; Ruffini L; Sterzi R; Causarano IR; Sberna M
    Eur J Nucl Med; 2000 Jan; 27(1):46-9. PubMed ID: 10654146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cerebral perfusion by means of planar brain scintigraphy and 99mTc-HMPAO in brain death, persistent vegetative state and severe coma.
    Schlake HP; Böttger IG; Grotemeyer KH; Husstedt IW; Brandau W; Schober O
    Intensive Care Med; 1992; 18(2):76-81. PubMed ID: 1613202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.
    Erba PA; Sollini M; Conti U; Bandera F; Tascini C; De Tommasi SM; Zucchelli G; Doria R; Menichetti F; Bongiorni MG; Lazzeri E; Mariani G
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1075-1086. PubMed ID: 24011775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.